Centre of Evidence Based Dermatology

STOP GAP trial on pyoderma gangrenosum featured in "NIHR Signal"


The STOP GAP trial comparing prednisolone and ciclosporin for pyoderma gangrenosum is now the subject of an "NIHR Signal".

NIHR Signals are "accessible, timely summaries of the most recent, relevant and important research". They are published every week on the NIHR Discover Portal.

Posted on Wednesday 14th October 2015

Centre of Evidence Based Dermatology

The University of Nottingham
Applied Health Research Building
University Park, Nottingham

telephone: +44 (0) 115 84 68631
email: cebd@nottingham.ac.uk